Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-12-22 RUBINSTEIN JULIE President Option exercise +15,000 $6.32 $95K 15,000
2020-12-22 RUBINSTEIN JULIE President Sale −13,100 $63.62 $833K 1,900
2020-12-22 RUBINSTEIN JULIE President Sale −1,900 $64.36 $122K 0
2020-12-22 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 470,000
2020-12-21 RUBINSTEIN JULIE President Option exercise +15,000 $6.32 $95K 15,000
2020-12-21 RUBINSTEIN JULIE President Sale −7,677 $59.15 $454K 7,323
2020-12-21 RUBINSTEIN JULIE President Sale −7,323 $59.72 $437K 0
2020-12-21 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 485,000
2020-12-21 Pellini Michael J Director Option exercise +25,000 $6.55 $164K 25,000
2020-12-21 Pellini Michael J Director Sale −25,000 $60.00 $1.5M 0
2020-12-21 Pellini Michael J Director Option exercise · Stock Option (Right to Buy) −25,000 75,000
2020-12-21 BENZENO SHARON Chief Business Development Off Option exercise +417 $6.27 $3K 417
2020-12-21 BENZENO SHARON Chief Business Development Off Sale −417 $59.14 $25K 0
2020-12-21 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −417 1,667
2020-12-15 HERSHBERG ROBERT Director Option exercise +2,000 $0.45 $900 2,000
2020-12-15 HERSHBERG ROBERT Director Sale −1,759 $55.78 $98K 241
2020-12-15 HERSHBERG ROBERT Director Sale −241 $57.01 $14K 0
2020-12-15 HERSHBERG ROBERT Director Option exercise · Stock Option (Right to Buy) −2,000 59,000
2020-12-15 LO FRANCIS Chief People Officer Option exercise +2,000 $7.80 $16K 2,000
2020-12-15 LO FRANCIS Chief People Officer Sale −1,759 $55.79 $98K 241

Page 79 of 120 · 2,386 trades